Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: the Australian Trial in Acute Hepatitis C

BACKGROUND: A barrier to hepatitis C virus (HCV) treatment among people who inject drugs (PWID) has been a concern that interferon-based HCV treatment may increase injecting risk behaviours. This study evaluated recent (past month) injecting risk behaviours during follow-up among PWID that did and d...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Drug Policy
Asıl Yazarlar: Alavi, Maryam, Spelman, Tim, Matthews, Gail V., Haber, Paul S., Day, Carolyn, van Beek, Ingrid, Walsh, Nick, Yeung, Barbara, Bruneau, Julie, Petoumenos, Kathy, Dolan, Kate, Kaldor, John M., Dore, Gregory J, Hellard, Margaret, Grebely, Jason
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4577441/
https://ncbi.nlm.nih.gov/pubmed/26115881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugpo.2015.05.003
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller